Latest Breaking News On - Katherine maynard - Page 1 : comparemela.com

Expert Office Hours offered at RARE Drug Development Symposium

The Regulatory Landscape: Pathways, End Points, and Clinical Trials - 2023 RARE Drug Development Symposium

The Regulatory Landscape: Pathways, End Points, and Clinical Trials - 2023 RARE Drug Development Symposium panel session

RARE-X Announces the Expansion of its Board of Directors to Support the Organization's Growth and Launch Efforts

RARE-X Announces the Expansion of its Board of Directors to Support the Organization’s Growth and Launch Efforts Share Article New members will enhance RARE-X’s programs, pilots, and operational expansion with strategic expertise and leadership “The additions of Cynthia Grossman, PhD, Jason Colquitt, and Simon Frost to the board are very strategic. All bring a depth of knowledge in patient advocacy, health tech, scaling-up organizations, and operational excellence,” said Nicole Boice, RARE-X Co-Founder/Executive Director. ALISO VIEJO, Calif. (PRWEB) February 10, 2021 RARE-X today announced three new board members who will help support the nonprofit’s work in structured patient data collection, responsible data sharing, and the promise of its Federated Data Sharing Platform for data sharing and analysis. The new board members are Cynthia Grossman, PhD, director at Biogen; Jason Colquitt, CEO of Across